Conference abstract · 8 Jun 2018
Case reportPublished 2015
Orphan Drug Designation within the Development Strategy
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Conference abstract · 31 Aug 2020
Regulatory Strategies for Orphan Drug Development on a Global Scale
Other · 2020
Drug Designing: Open Access
Editorial · 2012
Rational Use of Drugs: A Possible Role of Open Access Journals
Conference proceeding · Aug 2020
Open access literature databases for mandatory drug safety literature screening during clinical development and post market – equal access to new science for pharmaceutical companies.
More from this journal
The newest in Journal of Rare Disorders: Diagnosis & Therapy.
Commentary · 24 Jun 2025
Exploration of How mRNA Technology is Being Adapted for Rare Disease Treatment
Perspective · 24 Jun 2025
Integrative Approaches Combining Genomics for Precise Identification of Rare Diseases
Perspective · 24 Jun 2025
Utilization of Liquid Biopsy Techniques for Detecting Genetic and Protein Markers in Rare Disorders
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Rare Disorders: Diagnosis & Therapy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Marie Deneux”
- BylineArticles whose byline prints “Tim Adetona”
- BylineArticles whose byline prints “Frederic Pailloux”
- BylineArticles whose byline prints “Emmanuelle Voisin”

